Entremed (ENMD)

[RRGY2K]

I think ENMD-1198 is just one piece in a bigger puzzle. The Dr. Bair hire was because of PZ/2ME2/MKC-1 success prospects (maybe PZ/Temodar at Duke, for instance), not because of impending interim results from a PI study with longer term benefits.

Of today's announcements, the Celgene revenue announcement is of greater near term impact IMO, because it means that Thalidomide royalties will be carying the company further on higher sales, and the suggestion of a slower than expected rate of displacement by Revlimid.